XTL Biopharmaceuticals
+$0.07 (+1.87%) Today
+$0.01 (+0.26%) As of 10:00 PM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell XTLB and other ETFs, options, and stocks.
About XTLB
XTL Biopharmaceuticals Ltd. engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. Its pipeline includes hCDR1 and Erythropoietin.
CEO
Shlomo Spokone Shalev
Employees
8
Headquarters
Ramat Gan, HaMerkaz
Founded
1993
XTLB Key Statistics
Market Cap
21.30M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
17.92K
High Today
$3.81
Low Today
$3.73
Open Price
$3.77
Volume
5.31K
52 Week High
$6.69
52 Week Low
$2.00